Release Date: 2024-06-10

Radiological Evaluation of Lung Cancer

Fatma Durmaz (Author)

Release Date: 2024-06-10

Lung cancer stands as a prominent malignancy globally, ranking high in both incidence and mortality rates. It ranks as the second most frequent cancer diagnosis, regardless of gender. Although smoking is the main culprit behind lung cancer, radon and asbestos exposure can also play a role in its pathogenesis. Common symptoms include coughing, shortness of [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inThe Radiology of Cancer
    First Page69
    Last Page85
    DOIhttps://doi.org/10.69860/nobel.9786053359364.7
    Page Count17
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Lung cancer stands as a prominent malignancy globally, ranking high in both incidence and mortality rates. It ranks as the second most frequent cancer diagnosis, regardless of gender. Although smoking is the main culprit behind lung cancer, radon and asbestos exposure can also play a role in its pathogenesis. Common symptoms include coughing, shortness of breath, and notably, hemoptysis, with manifestations stemming from local tumors, intrathoracic spread, distant metastases, or paraneoplastic syndromes. The majority of lung cancer diagnoses occur symptomatically, typically at advanced stages, indicative of poor prognosis. Imaging modalities, such as, Computed Tomography (CT), Ultrasonography (US), Magnetic Resonance Imaging (MRI), chest Radiographs, Positron Emission Tomography combined with CT (PET-CT), and bone scintigraphy, play crucial roles in diagnosis and disease staging. Despite the prevalence of advanced-stage presentations, early detection of lung cancer remains paramount, as it offers patients the potential for curative treatment through the implementation of appropriate radiological techniques. Radiologists act as crucial members of the multidisciplinary team dedicated to lung cancer, contributing expertise throughout the patient journey - from initial screening and definitive diagnosis to treatment planning and evaluation of treatment response.

    Fatma Durmaz (Author)
    Associate Professor, Van Yuzuncu Yil University
    https://orcid.org/0000-0003-3089-7165
    3Dr. Fatma Durmaz is an Associate Professor in the Department of Radiology at Van Yuzuncu Yil University Faculty of Medicine. She was born in Van, Turkey. She graduate from Istanbul University faculty of medicine in 2012. She worked as a general practitioner at Van İpekyolu State Hospital from 2012 to 2013. Subsequently, in 2014, she began her residency in Radiology at Van Yüzüncü Yıl University Faculty of Medicine and worked as a resident physician. She completed her specialization in early 2019 and became a specialist doctor. After fulfilling her compulsory service at Hakkari State Hospital, she started working as a faculty member in the Department of Radiology at Van Yüzüncü Yıl University Faculty of Medicine. She continues her tenure at the same institution. She works in the field of cardiothoracic radiological imaging. Throughout her career, she has authored numerous research articles, oral presentations, and poster presentations. Dr. Durmaz is a member of several professional organizations, including the Turkish Society of Radiology, Europian Society of Radiology, The European Society of Cardiovascular Radiology, Turkish Society of Magnetic Resonance.

    • Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn) 2021;25(01):45–52

    • Prokop CS. Conventional and CT diagnostics of bronchial carcinoma. Radiologe 2010; 50: 675-83.

    • Gharraf, H. S., Mehana, S. M., & ElNagar, M. A. (2020). Role of CT in differentiation between subtypes of lung cancer; is it possible?. The Egyptian Journal of Bronchology, 14, 1 7.

    • Walter, F. M., Rubin, G., Bankhead, C., Morris, H. C., Hall, N., Mills, K., ... & Emery, J. (2015). Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. British journal of cancer, 112(1), S6-S13.

    • Bradley, S. H., Abraham, S., Callister, M. E., Grice, A., Hamilton, W. T., Lopez, R. R., ... & Neal, R. D. (2019). Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. British Journal of General Practice, 69(689), e827-e835.

    • Bradley, S. H., Abraham, S., Callister, M. E., Grice, A., Hamilton, W. T., Lopez, R. R., ... & Neal, R. D. (2019). Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. British Journal of General Practice, 69(689), e827-e835.

    • Ravanel JG. Evidence-based Imaging in Lung Cancer. A Systematic Review. J Thorac Imaging 2012; 27: 315-24.

    • Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997; 157: 849-55.

    • Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009; 253: 606-22.

    • Meerbeeck JP, Fennel DA, De Ruysscher DKM. Small-cell lung cancer. Lancet 2011; 378: 1741-55.

    • Glazer HS, Duncan-Meyer J, Aronberg DJ, Moran JF, Levitt RG, Sagel SS. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985; 157: 191-4.

    • Backhus L, Bhargava P, Bastawrous S, Mariam M, Michael M, Varghese T Jr. Radiographic evaluation of the patient with lung cancer: Surgical implications of imaging. Curr Probl Diagn Radiol 2013; 42: 84-98.

    • McCollough, C. H., Leng, S., Yu, L., & Fletcher, J. G. (2015). Dual-and multi-energy CT: principles, technical approaches, and clinical applications. Radiology, 276(3), 637-653.

    • Biederer J, Mirsadraee S, Beer M, Molinari F, Hintze C, Bauman G. MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging 2012; 3: 373-86.

    • Bak, S. H., Kim, C., Kim, C. H., Ohno, Y., & Lee, H. Y. (2022). Magnetic resonance imaging for lung cancer: a state-of-the-art review. Precision and Future Medicine, 6(1), 49-77.

    • Ohno Y, Koyama H, Yoshikawa T, Kishida Y, Seki S, Takenaka D, et al. Standard-, reduced-, and no-dose thin-section radiologic examinations: comparison of capability for nodule detection and nodule type assessment in patients suspected of having pulmonary nodules. Radiology 2017;284:562-73.

    • Ohno Y, Koyama H, Yoshikawa T, Seki S, Takenaka D, Yui M, et al. Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma diseases. J Magn Reson Imaging 2016;43:512-32.

    • Koyama H, Ohno Y, Seki S, Nishio M, Yoshikawa T, Matsumoto S, et al. Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules. Eur J Radiol 2015; 84:509-15.

    • Li B, Li Q, Chen C, Guan Y, Liu S A Systematic Review and Meta-analysis of the Accuracy of Diffusion- weighted MRI in the Detection of Malignant Pulmonary Nodules and Masses. Acad Radiol 2014; 21: 21-9.

    • Wu LM, Xu JR, Hua J, Gu HY, Chen J, Haacke EM et al. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses? Magn Reson Imaging. 2013; 31: 235-46.

    • Hafez, M. R., Sobh, E. S., Elsawy, S. B., & Abo-Elkheir, O. I. (2017). The usefulness of thoracic ultrasonography in diagnosis and staging of bronchogenic carcinoma. Ultrasound, 25(4), 200-212.

    • Singh, G., Singh, A., & Dave, R. (2023). An Update on WHO Classification of Thoracic Tumours 2021-Newly Described Entities and Terminologies. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 17(6), EE01-EE05

    • Wang, Y.; Zou, S.; Zhao, Z.; Liu, P.; Ke, C.; Xu, S. New insights into small-cell lung cancer development and therapy. Cell Biol. Int. 2020, 44, 1564–1576

    • Panunzio, A., & Sartori, P. (2020). Lung cancer and radiological imaging. Current radiopharmaceuticals, 13(3), 238-242.

    • Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol 2022;17(3):362–387

    • Chong S, Lee KS. Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung. Cancer Imaging 2007;7(1):195–201

    • Travis, W.D. Pathology and Diagnosis of Neuroendocrine Tumors. Thorac. Surg. Clin. 2014, 24, 257–266.

    • Owonikoko, T.K.; Ragin, C.C.; Belani, C.P.; Oton, A.B.; Gooding, W.E.; Taioli, E.; Ramalingam S.S. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J. Clin. Oncol. 2007, 25, 5570-5577.

    • Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H., Beasley, M. B., ... & Wistuba, I. (2015). The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. Journal of thoracic oncology, 10(9), 1243-1260.

    • Tsuta K, Kawago M, Inoue E et al (2013) The utility of the proposed IASLC/ ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 81(3):371–376

    • Gardiner N, Jogai S, Wallis A. The revised lung adenocarcinoma classification-an imaging guide. J Thoracic Disease 2014.

    • Travis, W.D., et al., International association for the study of lung cancer/American thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 2011. 6(2): p. 244- 85.

    • Cohen, J.G., et al., Lung adenocarcinomas: correlation of computed tomography and pathology findings. Diagn Interv Imaging, 2016. 97(10): p. 955-963.

    • Gaikwad A, Gupta A, Hare S et al (2012) Primary adenocarcinoma of lung: a pictorial review of recent updates. Eur J Radiol 81(12):4146–4155

    • -Sung, Y. E., Cho, U., & Lee, K. Y. (2020). Peripheral type squamous cell carcinoma of the lung: clinicopathologic characteristics in comparison to the central type. Journal of Pathology and Translational Medicine, 54(4), 290.

    • Gundepalli, S. G., & Tadi, P. (2020). Lung Pancoast Tumor.

    • Prokop CS. Conventional and CT diagnostics of bronchial carcinoma. Radiologe 2010; 50: 675-83.

    • Lim, W., Ridge, C. A., Nicholson, A. G., & Mirsadraee, S. (2018). The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quantitative imaging in medicine and surgery, 8(7), 709.

    • Aberle DR, Gamsu G, Henschke CI, Naidich DP, Swensen SJ. A consensus statement of the society of thoracic radiology. Screening for lung cancer with helical computed tomography. J Thorac Imaging 2001; 16: 65-8.

    • National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al; Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409

    • Zhao, Y. R., Xie, X., De Koning, H. J., Mali, W. P., Vliegenthart, R., & Oudkerk, M. (2011). NELSON lung cancer screening study. Cancer Imaging, 11(1A), S79.

    • Mendoza, D. P., Heeger, A., Mino-Kenudson, M., Lanuti, M., Shepard, J. A. O., Sequist, L. V., & Digumarthy, S. R. (2021). Clinicopathologic and longitudinal imaging features of lung cancer associated with cystic airspaces: a systematic review and meta-analysis. American Journal of Roentgenology, 216(2), 318-329.

    • Gottumukkala RV, Fintelmann FJ, Keane FK, Shepard JO. Cystic Lesions on Lung Cancer Screening Chest Computed Tomography: When Should We Be Concerned? Ann Am Thorac Soc. 2018;15(2):263-265.

    • Mascalchi M, Attinà D, Bertelli E, et al. Lung cancer associated with cystic airspaces. J Comput Assist Tomogr 2015;39:102-8.

    Share This Chapter!